Norway · Delayed Price · Currency is NOK Omda AS Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw 9% organic growth and a 25% EBITDA margin, driven by strong recurring revenue and the transformative Saab acquisition. Guidance remains robust despite FX headwinds, with AI adoption and disciplined capital allocation supporting future margin and growth targets.
-
Acquisition of Saab Public Safety Solutions significantly expands presence in the U.K., making it the largest market outside the Nordics and strengthening the emergency software portfolio. The deal is structured to minimize risk, with financial targets and integration plans in place.
-
Q1 2026 saw stable sales and growing recurring revenue, with EBITDA slightly down year-over-year. Guidance for 2026 is maintained, targeting NOK 500–525 million in revenue and 28–32% EBITDA margin, with strong M&A activity and AI initiatives supporting future growth.
Fiscal Year 2025
-
Record revenue and EBITDA in 2025, with strong recurring income and improved margins. AI now central to operations, boosting efficiency and reducing CapEx. 2026 guidance targets further growth, higher margins, and active M&A, supported by robust cash flow and low leverage.
-
Record 30% EBITDA margin and 14% revenue growth highlight a strong quarter, with recurring revenue at 94% and robust guidance for 2025–2026. M&A remains a key growth lever, with efficiency gains and margin expansion targeted.
-
Strong Q2 results with 16% revenue growth, record recurring revenues, and EBITDA margin more than doubling year-over-year. Guidance for 2025 and 2026 is reaffirmed, with continued focus on organic and inorganic growth, cost efficiency, and prudent M&A.
-
Q1 2025 saw 15% revenue growth, record recurring revenue, and a 22% EBITDA margin, driven by a decentralized model and two acquisitions. Guidance for 2025 and 2026 remains unchanged, with strong cost control and a focus on organic and M&A-driven growth.
Fiscal Year 2024
-
Record revenue and recurring income marked Q4 2024, with restructuring completed and strong cash discipline achieved. 2025 guidance targets NOK 460–485 million revenue and higher EBITDA margins, driven by organic growth and operational leverage.
-
Three acquisitions—Averia, Dermicus, and Predicare—strengthen emergency and imaging offerings, with integration expected to be smooth due to shared methodologies. Margin expansion is targeted through cost reductions and decentralization, aiming for a 30% EBITDA margin in H2 2025. Cash management improvements support ongoing M&A and operational stability.
-
Q3 2024 saw NOK 103 million in income, 21% EBITDA margin, and 6% recurring revenue growth. All business areas except Emergency performed well; cost reductions and decentralization are expected to improve margins in coming quarters.
-
Organic growth reached 5.4% in Q2 2024, with recurring revenues strong and low churn. EBITDA was flat year-over-year, impacted by high personnel costs and weak professional services, but cost-saving and productivity initiatives are underway. Margin improvement and further M&A remain key priorities.